A simple outpatient procedure may provide a majority of people who discontinue popular weight-loss drugs a way to prevent regaining their lost pounds, scientists reveal in a new study
(Verified: they are two different birds)
Many users report noticeable pain reduction within just 1-2 weeks of starting treatment, with continued improvements throughout their protocol
These GLP-1RAs include once-weekly dulaglutide, exenatide and semaglutide (yet to be approved in Australia) and once-daily liraglutide (Table 2)
Its not a one-size-fits-all, despite what social media is saying
However, the magnitude of some of these observational estimates (for example, relative reductions in cardiovascular or all-cause mortality exceeding 50%) is considerably larger than would be predicted from the randomized effect sizes of either class and is almost certainly inflated by residual and time-related confounding, including healthy-adherer and prevalent-user biases